PARP Inhibitor Efficacy Depends on CD8+ T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast Cancer.
暂无分享，去创建一个
G. Shapiro | J. Jonkers | S. Rottenberg | J. Castrillon | Michelle K. Li | A. Mehta | P. Bouwman | G. Wulf | Olmo Sonzogni | Jennifer L. Guerriero | Dan Wang | Tanvi H. Visal | Emily M. Cheney | Constantia Pantelidou | Aditi Kothari | Jocelin Pinto | Mateus De Oliveria Taveira | Anita K. Mehta